Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors

Medical Oncology

Volumn 13, Issue 3, 1996, Pages 167-176

  Ragnhammar, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cytokines; GM CSF; monoclonal antibodies

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CELL MEDIATED CYTOTOXICITY; HUMAN; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 0030437924     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02990844     Document Type: Review

References (64)

1. Burgess, A.W., Camakaris, J. and Metcalf, D. (1977) Purification and properties of colony stimulating factor from mouse lung conditioned medium. J. Biol. Chem. 252, 1998-2003.
2. Huebner, K., Isobe, M., Croce, C.M. et al. (1985) The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q-anomaly. Science 230, 1282-5.
3. Schrader, J.W., Ziltener, H.J. and Leslie, K.B. (1986) Structural homologies among the hemopoietins. Proc. Natl. Acad. Sci. USA 83, 2458-62.
4. Gearing, D.P., King, J.A. and Gough, N.M. (1989) Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 8, 3667-76.
5. Hayashida, K., Kitamura, T., Gorman, D.M. et al. (1990) Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA 87, 9655-9.
6. Clark, S.C. and Kamen, R. (1987) The human hematopoietic colony-stimulating factors. Science 236, 1229-37.
7. Dinarello, C.A. and Mier, J.W. (1987) Lymphokines. N. Engl. J. Med. 317, 940-5.
8. Colotta, F., Wang, J.M. and Polentarutti, N. (1987) Expression of c-fos protooncogene in normal human peripheral blood granulocytes. J. Exp. Med. 165, 1224-9.
9. Lindemann, A., Riedel, D., Oster, W. et al. (1988) Granulocyte/macrophage colony-stimulating factor induced interIeukin 1 production by human polymorphonuclear neutrophils. J. Immunol. 140, 837-9.
10. Cicco, N.A., Lindemann, A., Content, J. et al. (1990) Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 75, 2049-52.
11. Lindemann, A., Riedel, D., Oster, W. et al. (1989) Granulocyte-macrophage colony-stimulating factor induces cytokine secreting by human polymorphonuclear leukocytes. J. Clin. Invest. 83, 1308-12.
12. Villalta, F. and Kierszenbaum, F. (1986) Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (trypanosome cruzi) by human neutrophils. J. Immunol. 137, 1703-7.
13. Fabian, I., Baldwin, G.C. and Golde, D.W. (1987) Biosynthetic granulocyte-macrophage colony-stimulating factor enhances neutrophil cytotoxidty toward human leukemia cells. Leukemia 1, 613-7.
14. Weisbart, R.H., Kwan, L., Golde, D.W. et al. (1987) Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69, 18-21.
15. Masucci, G., Wersäll, P. and Ragnhammar, P. (1989) Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody dependent cellular cytotoxicity. Cancer Immunol. Immunother. 29, 288-92.
16. Liesveld, J.L., Abboud, C.N., Looney, R.J. et al. (1988) Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines. J. Immunol. 140, 1527-33.
17. Grabstein, K.H., Urdal, D.L., Tushinski, R.J., Mochizuki, D.Y., Price, V.L., Cantrell, M.A., Gillis, S. and Conlon, P.J. (1986) Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232, 506-8.
18. Yamashita, Y., Nara, N. and Aoki, N. (1989) Antiproliferative and differentiative effect of granulocyte-macrophage colony-stimulating factor on a variant human small cell lung cancer cell line. Cancer Res. 49, 5334-8.
19. Ruff, M.R., Farrar, W.L. and Pert, C.B. (1986) Interferon γ and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigen characteristic of myeloid differentiation in small-cell lung cancer cell lines. Proc. Natl. Acad. Sci. USA 83, 6613-7.
20. Baldwin, C.C., DiPersio, J., Kaufman, S.E., Quan, S.G., Golde, D.V. and Gasson, J.C. (1987) Characterization of human GM-CSF receptors on non hematopoietic cells. Blood 70, (suppl. 1), 166a.
21. Ragnhammar, P., Frödin, J-E., Trotta, P.P. and Mellstedt, H. (1994) Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol. Immunother. 39, 254-62.
22. Silberstein, D.S., Owen, W.F., Gasson, J.C., DiPersio, J.F., Golde, D.W., Bina, J.C., Sobermann, R., Austen, K.F. and David, J.F. (1986) Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol. 137, 3290-4.
23. Fidler, IJ. and Schroit, A.J. (1988) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim. Biophys. Acta 948, 151-73.
24. Nathan, C.F., Murray, H.C. and Cohn, Z.A. (1980) The macrophage as an effector cell. N. Engl. J. Med. 303, 622-6.
25. Hibbs, J.B. Jr (1974) Heterocytolysis by macrophages activated by bacillus Calmette-Guerin: lysosome exocytosis into tumor cells. Science 184, 468-71.
26. Yamauchi, N., Kuriyama, H., Watanabe, N., Neda, H., Maeda, M. and Niitsu, Y. (1989) Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res. 49, 1671-5.
27. Dillman, R.O. (1987) In R.K. Oldham (ed.) Principles of cancer biotherapy, pp. 291-318. New York: Raven Press, Ltd.
28. Liesveld, J.L., Frediani, K.E., Winslow, J.M., Duerst, R.E. and Abboud, C.N. (1991) Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity. J. Cell Biochem. 45, 381-90.
29. Connor, R.I., Shen, L. and Fanger, M.W. (1990) Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of FcγRI and FcγRII and the effects of cytokines at the single cell level. J. Immunol. 145, 1483-9.
30. Masucci, G., Wersäll, P., Ragnhammar, P. and Mellstedt, H. (1989) Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunol. Immunother. 29, 288-92.
31. Kushner, B.H. and Cheung, N-K.V. (1989) GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 73, 1936-41.
32. Epling-Burnette, P.K., Wei, S., Blanchard, D.K., Spanzi, E. and Djeu, Y. (1993) Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor. Blood 81, 3130-7.
33. Baxevanis, C.N., Dedoussis, G.V.Z., Papadopoulos, N.G., Missitzis, I., Beroukas, C., Stathopoulos, G.P. and Papamichail, M. (1995) Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor. Cancer 76, 1253-60.
34. Wos, E., Olencki, T., Tuason, L., Budd, G.T., Peereboom, D., Sandstrom, K., McLain, D., Finke, J. and Bukowski, R.M. (1996) Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma. Cancer 77, 1149-53.
35. Wing, E.J., Magee, D.M., Whiteside, T.L., Kaplan, S.S. and Shadduck, R.K. (1989) Recombinant human granulocyte/ macrophage colony-stimulating factor enhances monocyte cytotoxicity secretion of tumor necrosis factor α and interferon in cancer patients. Blood 73, 643-6.
36. Steis, R.G., VanderMolen, L.A., Longo, D.L., Clark, J.W., Smith, J.W., Kopp, W.C., Ruscetti, F.W., Creekmore, S.P., Elwood, L.J., Hursey, J. and Urba, W.J. (1990) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: A phase Ib trial. J. Natl. Cancer Inst. 82, 697-703.
37. Chachoua, A., Oratz, R., Hoogmoed, R., Caron, D., Peace, D., Liebes, L., Blum, R.H. and Vilcek, J. (1994) Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor. J. Immunother. 15, 217-24.
38. Bukowski, R.M., Murthy, S., McLain, D., Finke, J., Andresen, S., Tubbs, R., Bauer, L., Gibson, V., Budd, G.T. and Thomassen, M.J. (1993) Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: Clinical and immunologic effects. J. Immunother. 13, 267-74.
39. Lieschke, G.J., Maher, D., O'Connor, M., Green, M., Sheridan, W., Railings, M., Bonnem, E., Burgess, A.W., McGrath, K., Fox, R.M. and Morstyn, G. (1990) Phase I study of intravenously administered bacterially synthe-sized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Cancer Res. 50, 606-14.
40. Herrmann, F., Schultz, G., Lindemann, A., Meyenburg, W., Oster, W., Krumwieh, D. and Mertelsmann, R. (1989) Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. J. Clin. Oncol. 7, 159-67.
41. O'Donnell, R.T., Dea, G. and Meyers, F.J. (1995) A phase II trial of concomitant interferon-α-2b and granulocyte-macrophage colony-stimulating factor in patients with advanced renal cell carcinoma. J. Immunother. 17, 58-61.
42. Schiller, J.H., Hank, J.A., Khorsand, M., Storer, B., Borchert, A., Huseby-Moore, K., Burns, D., Wesly, O., Albertini, M.R., Wilding, G. and Sondel, P.M. (1996) Clinical and immunological effect of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: A phase IB study. Clin. Cancer Res. 2, 319-30.
43. Ragnhammar, P., Fagerberg, J., Frödin. J-E., Hjelm, A-L., Lindemalm, C., Magnusson, I., Masucci, G. and Mellstedt, H. (1993) Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma - long lasting, complete remissions can be induced. Int. J. Cancer 53, 751-8.
44. Ragnhammar, P., Masucci, G., Frödin, J-E., Hjelm, A-L. and Mellstedt, H. (1992) Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor. Cancer Immunol. Immunother. 35, 158-64.
45. Chachoua, A., Oratz, R., Liebes, L., Alter, R.S., Felice, A., Peace, D., Vilcek, J. and Blum, R.H. (1994) Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma. J. Immunother. Emphasis Tumor Immunol. 16, 132-41.
46. Schmid, I., Baldwin, G.C., Jacobs, E.L., Isacescu, V., Neagos, N., Giorgi, J.V. and Glaspy, J.A. (1995) Alterations in phenotype and cell-surface antigen expression levels of human monocytes: Differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry 22, 103-10.
47. Masucci, G., Ragnhammar, P., Wersäll, P. and Mellstedt, H. (1990) Granulocyte-monocyte colony-stimulating factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A). Cancer Immunol. Immunother. 31, 231-5.
48. Hjelm-Skog, A-L., Frödin, J-E., Ragnhammar, P., Goldinger, M., Koldestam, H., Liljefors, M., Wersäll, P. and Mellstedt, H. (1996) Effect of monoclonal antibody 17-1A, GM-CSF and IL-2 in patients with advanced colorectal carcinoma, (in manuscript).
49. Young, D.A., Lowe, L.D. and Clark, S.C. (1990) Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. J. Immunol. 145, 607-15.
50. Robin, G., Markovich, S., Athamna, A. and Keisary, Y. (1991) Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures. Lymphokine Cytokine Res. 10, 257-63.
51. Steis, R.G., VanderMolen, L.A., Longo, D.L., Clark, J.W., Smith, J.W., Kopp, W.C., Ruscetti, F.W., Creekmore, S.P., Elwood, L.J., Hursey, E.J. and Urba, W.J. (1990) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: A phase Ib trial. J. Natl. Cancer Inst. 82, 697-703.
52. Blanchard, D.K. and Dieu, J.Y. (1991) Differential modulation of surface antigens on human macrophages by IFN-gamma and GM-CSF. - Effect on susceptibility to LAK lysis. J. Leukoc. Biol. 50, 28-34.
53. Grabstein, K.H., Urdal, D.L., Tushinski, R.J., Mochizuki, D.Y., Price, V.J., Cantrell, M.A., Gillis, S. and Conlon, P.J. (1986) Induction of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor. Science 232, 506-8.
54. Arnaout, M.A., Wang, E.A., Clark, S.C. and Sieff, C.A. (1986) Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J. Clin. Invest. 78, 597-601.
55. Fischer, H.G., Frosch, S., Reske, K. and Reske-Kunz, A.B. (1988) GM-CSF activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 141, 3882-8.
56. Santoli, D., Clark, S.C., Kreider, B.L., Patricia, A.M., Maslin, A. and Rovera, G. Amplification of IL-2 driven T-cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony stimulating factor. J. Immunol. 141, 519-26.
57. Dranoff, G., Jaffee, E., Lazenby, A., Golumbeck, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. and Mulligan, R. (1993) Vaccination with irradiated tumor cells engineered to secret murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-43.
58. Steward, W.P., Scarffe, J.H., Austin, R., Bonnem, E., Thatcher, N., Morgenstern, G. and Crowther, D. (1989) Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions - a phase I dose-toxicity study. Br. J. Cancer 59, 142-5.
59. Boente, P., Sampaio, C., Brandao, M., Moreira, E., Badaro, R. and Jones, T. (1993) Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma. Lancer 341, 1154.
60. Herlyn, D., Herlyn, M., Ross, A.H., Ernst, C., Atkins, B. and Koprowski, H. (1984) Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J. Immunol. Methods. 73, 157-67.
61. Mellstedt, H., Frödin, J-E., Masucci, G., Ragnhammar, P., Fagerberg, J., Hjelm, A-L., Shetye, J., Wersäll, P. and Österborg, A. (1991) The therapeutic use of monoclonal antibodies in colorectal carcinoma. Semin. Oncol. 18, 462-77.
62. Tao, M-H. and Levy, R. (1993) Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362, 755-8.
63. Morrissey, P.J., Bressler, L., Park, L.S., Alpert, A. and Gilllis, S. (1987) Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139, 1113-9.
64. Hill, A.D.K., Redmond, H.P., Naama, H.A. and Bouchier-Hayes, D. (1995) Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period. Surgery 119, 178-85.